| | | | | | | | | | |
|
|
| Dockets Entered
On October 3, 2007
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
| 2000P-0788
|
| Totally Implanted Spinal Cord Stimulator
|
|
|
| 2001P-0230
|
| Domestic Marketing & Importation of Transgenic Fish
|
|
|
| 2006N-0454
|
| Use of Ozone-Depleting Substances; Removal of Essential-Use Designations
|
|
|
| 2006N-0475
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Human Tissue Intended for Transplantation
|
|
|
| 2006P-0124
|
| Stay any approvals of an Abbreviated New Drug Application (ANDA) for Vancocin Capsules
|
|
|
| 2006P-0307
|
| To amend 21CFR 201.17 regarding expiration dates
|
|
|
| 2007N-0018
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Human Cells, Tissues, and Cellular and Tissue-Based Products: Establishment Registration and Listing; Form FDA 3356; El
|
|
|
|
|
|
| 2007N-0343
|
| Electronic Nonclinical Study Data Submission; Notice of Pilot Project
|
|
|
| 2007N-0382
|
| Ramipril Capsules and 180-day generic drug exclusivity
|
|
|
| 2000P-0788
|
| Totally Implanted Spinal Cord Stimulator
|
|
|
| LET 3
|
| Anne E. Roan
|
| Vol #:
|
| 9
|
|
|
| 2001P-0230
|
| Domestic Marketing & Importation of Transgenic Fish
|
|
|
| EMC 3177
|
| T. Aldridge
|
| Vol #:
|
| 261
|
|
|
| EMC 3178
|
| P. Mahar
|
| Vol #:
|
| 261
|
|
|
| EMC 3179
|
| J. Barnett
|
| Vol #:
|
| 261
|
|
|
| EMC 3180
|
| M. Bedard
|
| Vol #:
|
| 261
|
|
|
| EMC 3181
|
| B. Tache and J. Tache
|
| Vol #:
|
| 261
|
|
|
| EMC 3182
|
| J. Landshof
|
| Vol #:
|
| 261
|
|
|
| EMC 3183
|
| R. Jacques
|
| Vol #:
|
| 261
|
|
|
| EMC 3184
|
| T. Truglas
|
| Vol #:
|
| 261
|
|
|
| EMC 3185
|
| D. Shaw
|
| Vol #:
|
| 261
|
|
|
| EMC 3186
|
| D. Martinez
|
| Vol #:
|
| 261
|
|
|
| EMC 3187
|
| M. Caniglia
|
| Vol #:
|
| 261
|
|
|
| EMC 3188
|
| J. Frontz
|
| Vol #:
|
| 261
|
|
|
| EMC 3189
|
| S. Mathans
|
| Vol #:
|
| 261
|
|
|
| EMC 3190
|
| E. Johnsen
|
| Vol #:
|
| 261
|
|
|
| EMC 3191
|
| M. Gentry
|
| Vol #:
|
| 261
|
|
|
| EMC 3192
|
| S. Sanati
|
| Vol #:
|
| 261
|
|
|
| EMC 3193
|
| J. Hamer
|
| Vol #:
|
| 261
|
|
|
| EMC 3194
|
| L. Ellsworth
|
| Vol #:
|
| 261
|
|
|
| EMC 3195
|
| A. Moore
|
| Vol #:
|
| 261
|
|
|
| EMC 3196
|
| M. Kowal
|
| Vol #:
|
| 261
|
|
|
| EMC 3197
|
| P. Alvarez
|
| Vol #:
|
| 261
|
|
|
| EMC 3198
|
| J. Lafolley
|
| Vol #:
|
| 261
|
|
| | | | | | | | |
|
|
| C 3847
|
| H Watford
|
| Vol #:
|
| 33
|
|
|
| C 3848
|
| F Howey
|
| Vol #:
|
| 33
|
|
|
| C 3849
|
| L Allen
|
| Vol #:
|
| 33
|
|
|
| C 3850
|
| J Burgess Sr
|
| Vol #:
|
| 33
|
|
|
| C 3851
|
| M Litterell
|
| Vol #:
|
| 33
|
|
|
| C 3852
|
| P Morin
|
| Vol #:
|
| 33
|
|
|
| C 3853
|
| J Heefner
|
| Vol #:
|
| 33
|
|
|
| C 3854
|
| D Paul
|
| Vol #:
|
| 33
|
|
|
| C 3855
|
| F Osterlund
|
| Vol #:
|
| 33
|
|
|
| C 3856
|
| M Looney
|
| Vol #:
|
| 33
|
|
|
| C 3857
|
| M Jones
|
| Vol #:
|
| 33
|
|
|
| C 3858
|
| B Brock
|
| Vol #:
|
| 33
|
|
|
| C 3859
|
| B Blasias
|
| Vol #:
|
| 33
|
|
|
| C 3860
|
| no signature
|
| Vol #:
|
| 33
|
|
|
| 2006N-0475
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Human Tissue Intended for Transplantation
|
|
|
| NAL 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| SS 1
|
| Supporting Statement
|
| Vol #:
|
| 1
|
|
|
| 2006P-0124
|
| Stay any approvals of an Abbreviated New Drug Application (ANDA) for Vancocin Capsules
|
|
|
| EMC 4
|
| D. Robertson
|
| Vol #:
|
| 1
|
|
|
| 2006P-0307
|
| To amend 21CFR 201.17 regarding expiration dates
|
|
|
| LET 6
|
| Sapna Lohiya
|
| Vol #:
|
| 1
|
|
|
| 2007N-0018
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Human Cells, Tissues, and Cellular and Tissue-Based Products: Establishment Registration and Listing; Form FDA 3356; El
|
|
|
|
|
|
|
| NAL 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| SS 1
|
| Supporting Statement
|
| Vol #:
|
| 1
|
|
|
| 2007N-0343
|
| Electronic Nonclinical Study Data Submission; Notice of Pilot Project
|
|
|
| N 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2007N-0382
|
| Ramipril Capsules and 180-day generic drug exclusivity
|
|
|
| LET 1
|
| Cobalt Pharmaceuticals, Inc.
|
| Vol #:
|
| 1
|
|
|
| LET 2
|
| Lupin Pharmaceuticals, Inc.
|
| Vol #:
|
| 1
|
|
|
| LET 3
|
| FDA/CDER/OGD
|
| Vol #:
|
| 1
|
|